259 related articles for article (PubMed ID: 22299262)
1. [CED therapy with infliximab. Rapid and lasting remission - complete mucosal healing].
Wedekind S
MMW Fortschr Med; 2011 Dec; 153(48):54-5. PubMed ID: 22299262
[No Abstract] [Full Text] [Related]
2. [Biological therapy as treatment of inflammatory bowel diseases].
Agnholt J
Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
[TBL] [Abstract][Full Text] [Related]
3. [What has been confirmed in the treatment of inflammatory bowel disease?].
Siegmund B; Preiss JC; Zeitz M
Internist (Berl); 2010 Dec; 51(12):1492-8. PubMed ID: 21069274
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding].
MMW Fortschr Med; 2008 Dec; 150(51-52):54-5. PubMed ID: 19156959
[No Abstract] [Full Text] [Related]
5. [Methotrexate in therapy of chronic inflammatory bowel diseases].
Schröder O; Stein J
Z Gastroenterol; 1996 Jul; 34(7):457-8. PubMed ID: 8928541
[No Abstract] [Full Text] [Related]
6. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
7. [Better to start from top?].
MMW Fortschr Med; 2005 Oct; 147(42):8. PubMed ID: 16281774
[No Abstract] [Full Text] [Related]
8. Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro.
Vos AC; Wildenberg ME; Arijs I; Duijvestein M; Verhaar AP; de Hertogh G; Vermeire S; Rutgeerts P; van den Brink GR; Hommes DW
Inflamm Bowel Dis; 2012 Mar; 18(3):401-8. PubMed ID: 21936028
[TBL] [Abstract][Full Text] [Related]
9. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
[TBL] [Abstract][Full Text] [Related]
10. Mucosal healing in inflammatory bowel disease: where do we stand?
Ha C; Kornbluth A
Curr Gastroenterol Rep; 2010 Dec; 12(6):471-8. PubMed ID: 20886319
[TBL] [Abstract][Full Text] [Related]
11. Short-term outcome of infliximab and other medications on patients with inflammatory bowel disease undergoing ileostomy reversal.
Regadas FS; Pinto RA; Murad-Regadas SM; Canedo JA; Leal M; Nogueras JJ; Wexner SD
Colorectal Dis; 2011 May; 13(5):555-60. PubMed ID: 20070344
[TBL] [Abstract][Full Text] [Related]
12. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].
Hellström PM; Schmidt D; Karlén P
Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308
[No Abstract] [Full Text] [Related]
13. [FAQs in chronic inflammatory bowel diseases. This way your patient stays in remission].
Stiefelhagen P
MMW Fortschr Med; 2011 Dec; 153(49-50):20-1. PubMed ID: 22308586
[No Abstract] [Full Text] [Related]
14. [Current medical treatment of inflammatory bowel disease].
Bosques-Padilla F
Rev Gastroenterol Mex; 2007 Nov; 72 Suppl 2():92-101. PubMed ID: 18277494
[No Abstract] [Full Text] [Related]
15. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural evidence of mucosal healing after infliximab in patients with ulcerative colitis.
Fratila OC; Craciun C
J Gastrointestin Liver Dis; 2010 Jun; 19(2):147-53. PubMed ID: 20593047
[TBL] [Abstract][Full Text] [Related]
17. [Drug therapy of inflammatory bowel diseases].
Silvennoinen J; Niemelä S
Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
[No Abstract] [Full Text] [Related]
18. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Colombel JF; Rutgeerts P; Reinisch W; Esser D; Wang Y; Lang Y; Marano CW; Strauss R; Oddens BJ; Feagan BG; Hanauer SB; Lichtenstein GR; Present D; Sands BE; Sandborn WJ
Gastroenterology; 2011 Oct; 141(4):1194-201. PubMed ID: 21723220
[TBL] [Abstract][Full Text] [Related]
19. Frequency and prognostic role of mucosal healing in patients with Crohn's disease and ulcerative colitis after one-year of biological therapy.
Farkas K; Lakatos PL; Szűcs M; Pallagi-Kunstár É; Bálint A; Nagy F; Szepes Z; Vass N; Kiss LS; Wittmann T; Molnár T
World J Gastroenterol; 2014 Mar; 20(11):2995-3001. PubMed ID: 24659890
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with infliximab and immunomodulators: is the glass half empty?
Deshpande AR; Abreu MT
Gastroenterology; 2008 Jun; 134(7):2161-3. PubMed ID: 18482585
[No Abstract] [Full Text] [Related]
[Next] [New Search]
